An adenoviral-vectored vaccine confers seroprotection against capsular group B meningococcal disease. - Dold C; Marsay L; Wang N; Silva-Reyes L; Clutterbuck E; Paterson GK; Sharkey K; Wyllie D; Beernink PT; Hill AV; Pollard AJ; Rollier CS (Science translational medicine, 2023)